文献速递慢性肾脏病遗传性与小管间质肾病

肾小管损伤:迈向慢性肾脏病的驱动力

Renal tubule injury: a driving force toward chronic kidney disease.
PubMed 文献 · Kidney Int · 2018-01-17

本文综述提出肾小管不仅是损伤受害者,更是肾脏病进展的驱动者。损伤后小管上皮细胞获得炎症和纤维化表型,通过先天免疫感知受体、坏死性炎症、部分上皮间质转化、细胞周期阻滞和代谢紊乱等机制驱动间质炎症与纤维化,加重肾损伤。

要点

  • 肾小管损伤后主动参与炎症和纤维化,驱动CKD进展。
  • 坏死性炎症是小管细胞死亡与间质炎症的自我放大环路。
  • 部分EMT、细胞周期阻滞和代谢紊乱是新近认识的小管驱动机制。

核心结论

  • 肾小管损伤是驱动慢性肾脏病进展的重要力量,而不仅是被动受害者。

研究设计与样本

  • 综述,未报告系统检索范围与样本量。

主要发现

  • 损伤后小管上皮细胞功能改变,作为炎症和纤维化细胞产生多种生物活性分子驱动间质炎症与纤维化。
  • 小管上皮的先天免疫感知受体加重免疫反应。
  • 坏死性炎症即小管细胞死亡与间质炎症之间的自我放大环路,导致肾损伤加重。
  • 部分上皮间质转化、G1/S和G2/M检查点细胞周期阻滞及代谢紊乱参与小管细胞驱动进行性肾损伤。

临床怎么用

  • 理解小管损伤驱动炎症和纤维化的机制,有助于开发阻止慢性肾脏病进展的治疗手段。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Renal tubules are the major component of the kidney and are vulnerable to a variety of injuries including hypoxia, proteinuria, toxins, metabolic disorders, and senescence. It has long been believed that tubules are the victim of injury. In this review, we shift this concept to renal tubules as a driving force in the progression of kidney diseases. In response to injury, tubular epithelial cells undergo changes and function as inflammatory and fibrogenic cells, with the consequent production of various bioactive molecules that drive interstitial inflammation and fibrosis. Innate immune-sensing receptors on the tubular epithelium also aggravate immune responses. Necroinflammation, an autoamplification loop between tubular cell death and interstitial inflammation, leads to the exacerbation of renal injury. Furthermore, tubular cells also play an active role in progressive renal injury via emerging mechanisms associated with a partial epithelial-mesenchymal transition, cell-cycle arrest at both G1/S and G2/M check points, and metabolic disorder. Thus, a better understanding the mechanisms by which tubular injury drives inflammation and fibrosis is necessary for the development of therapeutics to halt the progression of chronic kidney disease.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Liu BC, Tang TT, Lv LL, et al. Renal tubule injury: a driving force toward chronic kidney disease. Kidney Int. 2018. PMID: 29361307. doi:10.1016/j.kint.2017.09.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。